Human antibodies that bind human TNFalpha
Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha(hTNFalpha) are disclosed. These antibodies have high affinity for hTNFalpha (e.g., Kd=10-8 M or less), a slow off rate for hTNFalpha dissociation (e.g., Koff=10-3sec-1 or less) and...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
10.07.2001
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha(hTNFalpha) are disclosed. These antibodies have high affinity for hTNFalpha (e.g., Kd=10-8 M or less), a slow off rate for hTNFalpha dissociation (e.g., Koff=10-3sec-1 or less) and neutralize hTNFalpha activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNFalpha and for inhibiting hTNFalpha activity, e.g., in a human subject suffering from a disorder in which hTNFalpha activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. |
---|---|
AbstractList | Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha(hTNFalpha) are disclosed. These antibodies have high affinity for hTNFalpha (e.g., Kd=10-8 M or less), a slow off rate for hTNFalpha dissociation (e.g., Koff=10-3sec-1 or less) and neutralize hTNFalpha activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNFalpha and for inhibiting hTNFalpha activity, e.g., in a human subject suffering from a disorder in which hTNFalpha activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. |
Author | ALLEN DEBORAH J HOOGENBOOM HENDRICUS R. J. M SCHOENHAUT DAVID WILTON ALISON J LABKOVSKY BORIS SAKORAFAS PAUL SALFELD JOCHEN G WHITE MICHAEL ROBERTS ANDREW J MANKOVICH JOHN A KAYMAKCALAN ZEHRA MCGUINNESS BRIAN T VAUGHAN TRISTAN J |
Author_xml | – fullname: HOOGENBOOM HENDRICUS R. J. M – fullname: KAYMAKCALAN ZEHRA – fullname: WHITE MICHAEL – fullname: SAKORAFAS PAUL – fullname: SALFELD JOCHEN G – fullname: ALLEN DEBORAH J – fullname: MANKOVICH JOHN A – fullname: WILTON ALISON J – fullname: LABKOVSKY BORIS – fullname: SCHOENHAUT DAVID – fullname: VAUGHAN TRISTAN J – fullname: MCGUINNESS BRIAN T – fullname: ROBERTS ANDREW J |
BookMark | eNrjYmDJy89L5WTQ9CjNTcxTSMwryUzKT8lMLVYoyUgsUUjKzEtRyABLhfi5JeYUZCTyMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JL40GAzI1MLUzMjJ0NjIpQAAGujKbI |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
Edition | 7 |
ExternalDocumentID | US6258562B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US6258562B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:08:59 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US6258562B13 |
Notes | Application Number: US19990125098 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010710&DB=EPODOC&CC=US&NR=6258562B1 |
ParticipantIDs | epo_espacenet_US6258562B1 |
PublicationCentury | 2000 |
PublicationDate | 20010710 |
PublicationDateYYYYMMDD | 2001-07-10 |
PublicationDate_xml | – month: 07 year: 2001 text: 20010710 day: 10 |
PublicationDecade | 2000 |
PublicationYear | 2001 |
RelatedCompanies | BASF AKTIENGESELLSCHAFT |
RelatedCompanies_xml | – name: BASF AKTIENGESELLSCHAFT |
Score | 2.5402157 |
Snippet | Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha(hTNFalpha) are disclosed. These... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE |
Title | Human antibodies that bind human TNFalpha |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010710&DB=EPODOC&locale=&CC=US&NR=6258562B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5Kfd40KtYXe5CAh2CCm4eHIORFEZoWm0hvJZvdYi5JMRH_vrNrU73odRf2MTCPb3e-GYBb1-KPCH1Wxoo7nkERfhnyt8YwXZdJnicTVJKTJ6kzzunzwl4MoOq5MKpO6KcqjogaVaK-d8per38esSKVW9neswqHmqck8yO9R8eW9Jh6FPjxbBpNQz0M_Xyupy8-hvkeuvoAgdKOjKJlmf34NZCklPVvj5Icwe4MF6u7YxiIWoODsG-8psH-ZPPfrcGeStAsWxzcKGF7Anfq4Z2gSCrWyCRA0r0VHUGIy4lquUeyNFEc2lMgSZyFYwN3X25vuszn23M-nMGwbmpxDqTwuG0JalMhXFow5lFelihjx-SmW3AxgtGfy1z8M3cJh98ZVS4a4ysYdu8f4hpdbMdulHC-AJ9kf4U |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KfdSbVsX63IMEPARb3GTjIQhJGqK2abGp9Fay2S3mkhQT8e87u7bVi153YR8D8_h255sBuGY9cY_QZ2EuhO2YFOGXqX5rzC5jXPE8uaSKnDyM7WhKn2bWrAH5mguj64R-6uKIqFEZ6nut7fXy5xEr0LmV1S3Pcah8CBM3MNbouKc8phF4bn88Cka-4fvudGLELy6G-Q66eg-B0hZTxXlV5PTqKVLK8rdHCfdhe4yLFfUBNGTRhpa_brzWht3h6r-7DTs6QTOrcHClhNUh3OiHd4IiyXmpkgBJ_ZbWBCGuILrlHkniUHNoj4CE_cSPTNx9vrnpfDrZnPPuGJpFWcgTIKkjrJ6kFpWS0ZRzh4osQxnbXdFlqZAd6Py5zOk_c1fQipLhYD54jJ_PYO87u4qhYT6HZv3-IS_Q3db8UgvqC76ignI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Human+antibodies+that+bind+human+TNFalpha&rft.inventor=HOOGENBOOM+HENDRICUS+R.+J.+M&rft.inventor=KAYMAKCALAN+ZEHRA&rft.inventor=WHITE+MICHAEL&rft.inventor=SAKORAFAS+PAUL&rft.inventor=SALFELD+JOCHEN+G&rft.inventor=ALLEN+DEBORAH+J&rft.inventor=MANKOVICH+JOHN+A&rft.inventor=WILTON+ALISON+J&rft.inventor=LABKOVSKY+BORIS&rft.inventor=SCHOENHAUT+DAVID&rft.inventor=VAUGHAN+TRISTAN+J&rft.inventor=MCGUINNESS+BRIAN+T&rft.inventor=ROBERTS+ANDREW+J&rft.date=2001-07-10&rft.externalDBID=B1&rft.externalDocID=US6258562B1 |